Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-86,142
Closed -$644K 730
2025
Q2
$644K Hold
86,142
﹤0.01% 959
2025
Q1
$601K Sell
86,142
-727
-0.8% -$7.4K ﹤0.01% 907
2024
Q4
$695K Sell
86,869
-65,131
-43% -$569K ﹤0.01% 910
2024
Q3
$1.45M Hold
152,000
﹤0.01% 813
2024
Q2
$1.06M Hold
152,000
﹤0.01% 869
2024
Q1
$2.05M Sell
152,000
-69,700
-31% -$795K 0.01% 751
2023
Q4
$1.03M Hold
221,700
﹤0.01% 841
2023
Q3
$1.56M Buy
221,700
+4,700
+2% +$36.8K 0.01% 760
2023
Q2
$1.74M Hold
217,000
0.01% 755
2023
Q1
$1.62M Buy
217,000
+3,000
+1% +$16.8K 0.01% 798
2022
Q4
$1.07M Buy
214,000
+14,000
+7% +$79.3K ﹤0.01% 873
2022
Q3
$1.26M Buy
200,000
+13,800
+7% +$119K 0.01% 824
2022
Q2
$1.71M Hold
186,200
0.01% 798
2022
Q1
$3.56M Buy
186,200
+5,200
+3% +$105K 0.01% 737
2021
Q4
$4.16M Buy
181,000
+6,000
+3% +$138K 0.01% 711
2021
Q3
$5.12M Buy
+175,000
New +$5.54M 0.01% 673

Other funds holding NYXH

Axa's NYXH Position: Q3 2025 in Review

Axa sold out of Nyxoah (NYXH) in Q3 2025, closing a stake of 86,142 shares — an estimated $644K sold.

Axa first reported a position in NYXH in Q3 2021 and held it in 16 quarters. The position peaked at $5.12M in Q3 2021. 32 funds tracked by Wall St. Rank hold NYXH as of Q3 2025.

  • Axa reported no remaining Nyxoah position as of Q3 2025 after selling out during the quarter.
  • Axa sold 86,142 Nyxoah shares in Q3 2025, an estimated $644K.
  • Axa first reported a position in Nyxoah in Q3 2021 and held it in 16 quarters.
  • Axa's Nyxoah position peaked at $5.12M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Nyxoah as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.